ArticleFrontiers in bioengineering and biotechnology2025
Two-step purification of elastin-like polypeptide-fusion superoxide dismutase via hydrophobicity and thermoresponsiveness.
Article in Frontiers in bioengineering and biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Superoxide dismutase (SOD) catalyzes the dismutation of superoxide radicals to oxygen and hydrogen peroxide, serving as a key antioxidant enzyme with important therapeutic and industrial applications. However, the purification of recombinant SOD remains challenging due to low expression levels and the complexity of traditional purification methods, which involve time-consuming and multi-step chromatography. Elastin-like polypeptides (ELPs) offer a promising alternative due to their hydrophobic and thermoresponsive properties, which can be leveraged for non-chromatographic purification. Methods: A fusion protein of human SOD and an ELP tag (hSOD-ELP) was produced. The purification strategy consisted of two sequential steps. First, foam separation was employed, exploiting the hydrophobicity of the ELP to selectively adsorb hSOD-ELP at the gas-liquid interface. Second, inverse transition cycling (ITC) was used to further purify hSOD-ELP by exploiting ELP's thermoresponsiveness. Results: Under optimized conditions (0.4 mg/mL protein, 30 °C), the initial foam separation step achieved an enrichment ratio of 1.93, a protein recovery of 85.67%, an enzyme activity enrichment of 2.15, and an activity recovery of 93.32%. The subsequent ITC step yielded a recovery rate of 91.98% and a purification fold of 17.45. The cumulative two-step process resulted in a total yield of 85.84% and overall purification fold of 37.52, yielding the purified hSOD-ELP with a final purity of approximately 85%. Discussion: These results demonstrate that ELP-mediated purification offers a scalable and economical alternative to conventional methods. The combination of foam separation and thermal precipitation minimizes the need for expensive chromatography, making this strategy particularly promising for industrial-scale biotechnological applications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.